Enhancing the CONSORT initiative: renewal of intellectual support for the CONSORT Group

随机试验为医疗干预的有效性（和危害）提供了最好的证据;它们是循证医学实践的重要组成部分。因此，对审判进行适当的报告，对于确保花费巨大努力和费用进行的审判产生最大效益至关重要。然而，大量的证据表明，随机试验的报告远远不够理想。CONSORT（报告试验的统一标准）声明于1996年制定，旨在改善随机试验的报告。如果随机试验没有得到很好的报告，临床医生就很难使用最佳证据来告知最佳实践;患者可能无法得到最好的护理。CONSORT集团的主要产品是CONSORT声明，这是一个基于证据的最低限度的随机试验报告建议。CONSORT以清单和流程图的形式为作者提供了一种标准的方法来编写试验结果报告，促进他们完整和透明的报告，并帮助他们进行批判性评估和解释。CONSORT声明最初发布于1996年，于2001年进行了更新，最近一次更新是在2010年。此外，还为特定类型的随机试验开发了几种扩展。现在有越来越多的证据表明CONSORT对已发表文章的质量产生了有益的影响。CONSORT被全球数百种医学期刊使用和认可。CONSORT网站每年被浏览近25万次。重要的是，CONSORT要不断更新，以反映新的证据和不断变化的意见。2005年，CONSORT集团成功地获得了卫生技术评估研究方法计划的五年资助，以支持其活动并对建议进行重大更新。这笔资金即将结束，我们现在寻求延期，以使我们能够继续支持和加强CONSORT集团的工作。我们概述了与CONSORT声明及其扩展相关的四个广泛的、相互关联的计划活动领域：继续完善和更新指南;继续努力改善CONSORT的实施和遵守;开展与随机试验报告方式相关的研究;提供重要的基础设施以支持CONSORT小组的活动。

Randomized trials provide the best evidence of the effectiveness (and harms) of health care interventions; they are a crucially important part of the practice of evidence-based medicine. Proper reporting of trials is thus essential to ensure maximum benefit accrues from the trials conducted at great effort and expense. Yet a wealth of evidence shows that reporting of randomized trials is well short of ideal. The CONSORT (Consolidated Standards of Reporting Trials) Statement was developed in 1996 to try to improve the reporting of randomized trials. If randomized trials are not well reported it is difficult for clinicians to use best evidence to inform best practice; patients may not get the best care.The main product of CONSORT Group is the CONSORT Statement, an evidence-based, minimum set of recommendations for reporting randomized trials. In the form of a checklist and flow diagram, CONSORT offers a standard way for authors to prepare reports of trial findings, facilitating their complete and transparent reporting, and aiding their critical appraisal and interpretation. Originally published in 1996, the CONSORT Statement was updated in 2001 and mostly recently in 2010. In addition, several extensions have been developed for specific types of randomized trials. There is now a large and increasing body of evidence that CONSORT has had a beneficial impact on the quality of published articles. CONSORT is used and endorsed of by hundreds of medical journals worldwide. The CONSORT website is viewed nearly a quarter of a million times, annually. It is important that CONSORT is kept up to date to reflect new evidence and changing opinion. In 2005, the CONSORT Group successfully received five year funding from the Health Technology Assessment Research Methodology Programme to support its activities and develop a major update of the recommendations. That funding is coming to the end and we now seek a renewal to enable us to continue to support and enhance the work of the CONSORT Group. We outline four broad, interlinked areas of planned activity relating to the CONSORT Statement and its extensions: to continue to refine and update the guidelines; to continue efforts to improve the implementation of and adherence to CONSORT; to conduct relevant research relating to how randomized trials are reported; and to provide vital infrastructure to support the activities of the CONSORT Group.